[Hormone effects of the administration of 50 mg of dehydroepiandrosterone (DHEAS) intravenously in pregnant women (author's transl)].
The DHEAS overload test has been regarded by C. Lauritzen as reflecting the conditions of placental function. Some will support and some will oppose that test. We have merely concerned ourselves with conducting an examination into the metabolic outcome of the DHEAS overload.  --by defining the way in which oestriolury variations are best express themselves. --by estimating how reliable such variations are in cases where foetal pain and hypotrophy are diagnosed. --by going through a statistical analysis of other hormonal variations.
D015068:17-Ketosteroids / Q000652:urine; D003687:Dehydroepiandrosterone; D004964:Estriol / Q000652:urine*; D005260:Female; D005316:Fetal Distress / Q000175:diagnosis; D005865:Gestational Age; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006914:Hydroxysteroids / Q000652:urine; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000378:metabolism*; D011276:Pregnanediol / Q000097:blood; D013739:Testosterone / Q000097:blood
D015068:17-Ketosteroids; D006914:Hydroxysteroids; D013739:Testosterone; D003687:Dehydroepiandrosterone; D004964:Estriol; D011276:Pregnanediol; D006854:Hydrocortisone
Effets hormonaux de l'administration intraveineuse de 50 mg de déhydroépiandrostérone (DHEAS) chez la femme enceinte.